Form D · Biotechnology

Calysta, Inc.

Menlo Park, CA · CIK 0001521645

Offering snapshot reported Oct 11, 2019 · SEC filing

Reported sold
$45.2M
Offering amount: $120M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 10, 2019
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 11, 2019Initial$45,224,994No comparison18SEC filing
May 26, 2011Initial$5,000,000No comparison32SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-350933

Source: Form D, filed Oct 11, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Craig Barratt, Ph.D. Director
Claes Gustafsson Director
David Hayes Director
David Mc Elroy Director, Executive
Jeremy Minshull Director
Alan Shaw, Ph.D. Director, Executive
Joshua Silverman Executive
Suan Swee Tan Director
Rich Torres Director
Mike Velings Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1140 O'brien Drive
Menlo Park, CA, 94025